Taken together, these findings suggest that PEDF may be an indicator of infiltrative GSCs and a prognostic marker of low grade glioma and that it could be a crucial therapeutic target for the future treatment of glioma. This evidence concerns the gene SERPINF1 and central nervous system cancer.